Arcturus (ARCT) is a leader in the application of RNA technologies in the liver, lung, and muscle for the treatment of rare disease and vaccines with applications in immuno-oncology and in vivo gene editing/CAR-T.

***ARCT is not interested in additional CRO or other service providers at this time. We will not be accepting these requests.***